ScholarLens Back to search
2010•The American Journal of CardiologyRequires access

Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)

Christopher P. Cannon, Karen E. Rhee, Robert M. Califf, William E. Boden, Alan T. Hirsch, Mark J. Alberts, Greg Cable, Mingyuan Shao, E. Magnus Ohman, Philippe Gabríel Steg, Kim A. Eagle, Deepak L. Bhatt

Open publisher page 58 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 58 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Aspirin, Medicine, Antithrombotic, Internal medicine, Atrial fibrillation, Diabetes mellitus, Medical prescription, Fibrinolytic agent

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry) — Research Paper | ScholarLens